维普期刊资源整合服务平台（V6.5）

84篇 您的检索式：作者名="CROSS NC"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Laboratory recommendations for scoring deep molecular responses following treatment/'or chronic- myeloid leukemia显示文摘	Cross NC White HE Colomer D	2015	Leukemia2015，29，5：	1
2	Rapid identification of JAK2 exon,12 mutations using high resolution melting analysis显示文摘	Jones AV Cross NC White HE		0，，10：	1
3	Methylation-sensitive high-resolution melting-curve analysis of the SNRPN gene as a diagnostic screen for Pmder-Willi and Angelman syndromes显示文摘	White HE Hall VJ Cross NC	2007	Clin Chem2007，53，11：	1
4	Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials显示文摘	Branford S Fletcher L Cross NC	2008	{H}Blood2008，，8：	1
5	Aberrations of EZH2 in cancer 显示文摘	Chase A Cross NC	2011	Clinical cancer research : an official journal of the American Association for Cancer Research2011，17，9：	1
6	Durable responses to imatinib in patients with PDGFRB fusion gene--positive and BCR-ABL--negative chronic myeloproliferative disorders 显示文摘	David M Cross NC Burgstaller S	2007	Blood2007，109，1：	1
7	Harmonization of molecular monitoring of CML therapy in Europe显示文摘	Müller MC Cross NC Erben P		0，，11：	1
8	Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable显示文摘	Zoi K Cross NC	2015	Int J Hematol2015，101，3：	1
9	Standardisation of molecular monitoring for chronic myeloid leukaemia显示文摘	Cross NC		0，，3：	1
10	Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion显示文摘	Dolan M Cioc A Cross NC		0，，01：	1
11	Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders 显示文摘	Cross NC Reiter A	2008	Acta Haematol2008，119，4：	1
12	Homozygous deletions of the P16 tumor suppressor gene are associated with lymphoid transformation of chronic mycloid leukemia显示文摘	Sill H Goldman JM Cross NC	1995	Blood1995，85，：	1
13	Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia显示文摘	Dazzi F Szydlo RM Cross NC	2000	Blood2000，96，：	1
14	Genetic and epigenetic complexity in myeloproliferative neoplasms 显示文摘	Cross NC	2011	Hematology Am Soc Hematol Educ Program2011，2011，1：	1
15	Harmonization of molecu-lar monitoring of CML therapy in Europe 显示文摘	Muller MC Cross NC Erben P	2009	Leukemia2009，23，11：	1
16	Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia 显示文摘	Dazzi F Szydlo RM Cross NC	2000	Blood2000，96，8：	1
17	Competitive polymerase chain reaction to estimate the number of bcr-abl transcripts in chronic myeloid leukemia patients after bone marrow transplantation显示文摘	Cross NC Feng L Chase A	1993	Blood1993，82，6：	1
18	Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase:correlations with acute graft-versus-host disease and relapse显示文摘	CROSS NC HUGHES TP FENG L	1993	Br J Haematol1993，84，1：	1
19	Oncogenic derivatives of platelet-derived growth factor receptors 显示文摘	Jones AV Cross NC	2004	Cell Mol Life Sci2004，61，23：	1
20	Homozygous deletions of p16 tumour suppressor gene are associated with lymphoid transformation ofchrorfic myeloid leukemia显示文摘	Sill H Goldman JM Cross NC	1995	Blood1995，85，8：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示